About this Calculator

Understanding how the liver metabolizes and eliminates drugs is a cornerstone of pharmacokinetics. This guide provides a detailed explanation of the concepts behind the Hepatic Clearance Calculator, helping you interpret its results and understand the key factors influencing how drugs are processed by the liver.

What This Calculator Does

The calculator estimates two primary pharmacokinetic parameters:

• Hepatic Clearance (CLH): The volume of blood perfusing the liver that is cleared of a drug per unit of time. It quantifies the liver’s efficiency in eliminating a drug.
• Hepatic Extraction Ratio (EH): The fraction of the drug that is removed from the blood during a single pass through the liver. It’s a dimensionless value between 0 and 1.

It performs these calculations using two different physiological models: the Well-Stirred Model and the Parallel Tube Model, allowing for a comparison of different theoretical approaches.

When to Use It

This tool is valuable in various contexts:

• Educational Purposes: For students of pharmacy, medicine, and pharmacology to visualize the relationship between key parameters like blood flow, protein binding, and intrinsic clearance.
• Early Drug Development: Researchers can use in vitro data (CLint, fu) to predict in vivo hepatic clearance and classify compounds early in the discovery process.
• Clinical Research: To understand how physiological changes (e.g., liver disease affecting blood flow or protein binding) might impact a drug’s clearance and dosing regimen.

Inputs Explained

Pharmacokinetic Model

You can select between two classical models. The Well-Stirred Model assumes the drug concentration in the liver is uniform and equal to the exiting venous blood concentration. The Parallel Tube Model considers the gradual decrease in drug concentration as blood flows through the liver sinusoids.

Fraction Unbound (fu)

This is the fraction of drug in the plasma that is not bound to proteins (like albumin). Only the unbound drug is available to be metabolized by liver enzymes. It is a unitless value between 0 (fully bound) and 1 (no binding).

Liver Blood Flow (QH)

This represents the rate of blood flow to the liver. It is a major determinant of clearance for certain drugs. A typical value for a 70 kg adult is approximately 1500 mL/min or 90 L/hr.

Intrinsic Clearance (CLint)

This reflects the intrinsic metabolic capacity of the liver enzymes to eliminate a drug, independent of blood flow or protein binding. It’s often determined from in vitro experiments using liver microsomes or hepatocytes.

Results Explained

Hepatic Clearance (CLH)

This is the final calculated value, representing the overall efficiency of drug elimination by the liver. The units (L/hr or mL/min) will match the units you selected for the inputs.

Hepatic Extraction Ratio (EH)

This ratio classifies the drug’s elimination characteristics:

• High Extraction (EH > 0.7): The liver removes over 70% of the drug in one pass. Clearance is primarily dependent on liver blood flow (QH). This is known as “flow-limited” clearance.
• Low Extraction (EH < 0.3): The liver removes less than 30% of the drug. Clearance is sensitive to changes in both fraction unbound (fu) and intrinsic clearance (CLint). This is known as “capacity-limited” clearance.
• Intermediate Extraction (0.3 ≤ EH ≤ 0.7): Clearance is sensitive to all three factors: QH, fu, and CLint.

Formula / Method

The calculator uses the following standard formulas depending on the selected model:

Well-Stirred Model

CLH = QH * [ (fu * CLint) / (QH + fu * CLint) ]

Parallel Tube Model

CLH = QH * [ 1 - e^(-(fu * CLint / QH)) ]

In both cases, the Extraction Ratio (EH) is calculated as EH = CLH / QH.

Step-by-Step Example

Let’s calculate the hepatic clearance for a hypothetical drug using the Well-Stirred Model.

Given Parameters:

• Liver Blood Flow (QH) = 90 L/hr
• Intrinsic Clearance (CLint) = 500 L/hr
• Fraction Unbound (fu) = 0.1

Step 1: Calculate the product of fu * CLint.

fu * CLint = 0.1 * 500 L/hr = 50 L/hr

Step 2: Plug the values into the Well-Stirred formula.

CLH = 90 * [ 50 / (90 + 50) ]

CLH = 90 * [ 50 / 140 ]

CLH = 90 * 0.357

CLH ≈ 32.14 L/hr

Step 3: Calculate the Extraction Ratio (EH).

EH = CLH / QH = 32.14 L/hr / 90 L/hr ≈ 0.357

Conclusion: The hepatic clearance is 32.14 L/hr, and with an extraction ratio of 0.357, this drug is classified as having Intermediate Extraction.

Tips + Common Errors

• Unit Consistency: Ensure that QH and CLint are in the same units (either L/hr or mL/min). The calculator handles this by syncing the unit dropdowns.
• Fraction vs. Percentage: The Fraction Unbound (fu) must be entered as a decimal (e.g., 0.05 for 5% unbound), not a percentage.
• Model Limitations: Remember these are simplified models. They don’t account for factors like active transport into the liver or biliary excretion, which can also affect clearance.
• Zero Values: All input values must be greater than zero. Fraction unbound can be zero, but this is biologically implausible and would result in zero clearance.

Frequently Asked Questions (FAQs)

1. What is the main difference between the Well-Stirred and Parallel Tube models?

The Well-Stirred model assumes drug concentration within the liver is uniform, which can underestimate the clearance of high-extraction drugs. The Parallel Tube model accounts for a concentration gradient along the liver sinusoid, often providing a more physiologically realistic estimate, especially for flow-limited drugs.

2. Why is only the unbound drug cleared?

Drugs bound to plasma proteins are too large to pass through the fenestrations in liver sinusoids to reach the hepatocytes (liver cells) where metabolic enzymes are located. Therefore, only the free, unbound fraction is available for metabolism.

3. How does liver disease affect hepatic clearance?

Liver disease can impact clearance in multiple ways: it can reduce the number of functional hepatocytes (decreasing CLint), cause scarring that reduces liver blood flow (decreasing QH), and lead to lower plasma protein levels (increasing fu). The net effect on a drug’s clearance depends on which of these factors are most affected and the drug’s extraction ratio.

4. What does “flow-limited” clearance mean for dosing?

For a high-extraction, flow-limited drug, changes in liver blood flow have a significant impact on clearance. For example, a condition that reduces blood flow (like severe heart failure) can dramatically decrease the drug’s clearance, leading to higher drug levels and potential toxicity.

5. What does “capacity-limited” clearance mean?

For a low-extraction, capacity-limited drug, clearance is less dependent on blood flow and more on the enzyme’s capacity (CLint) and drug binding (fu). Drug interactions that inhibit or induce metabolic enzymes will have a large effect on this type of drug.

6. Can this calculator be used for drugs cleared by the kidneys?

No. This calculator is specifically for hepatic (liver) clearance. Renal (kidney) clearance involves different processes like glomerular filtration, tubular secretion, and reabsorption, and requires a different set of parameters and formulas.

7. Where do the values for CLint and fu come from?

These are typically determined experimentally. Intrinsic clearance (CLint) is often measured in vitro using human liver microsomes or hepatocytes. Fraction unbound (fu) is measured using techniques like equilibrium dialysis.

8. Does a high CLint always mean high hepatic clearance (CLH)?

Not necessarily. A drug can have a very high intrinsic clearance but also be very highly bound to plasma proteins (low fu). In this case, the product of fu * CLint might be low, leading to low overall hepatic clearance. This is common for low-extraction drugs.

References

1. Rowland, M., & Tozer, T. N. (2011). Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications (4th ed.). Lippincott Williams & Wilkins.
2. Wilkinson, G. R., & Shand, D. G. (1975). A physiological approach to hepatic drug clearance. Clinical Pharmacology & Therapeutics, 18(4), 377-390. DOI: 10.1002/cpt1975184377
3. Pang, K. S., & Rowland, M. (1977). Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. Journal of Pharmacokinetics and Biopharmaceutics, 5(6), 625-653. DOI: 10.1007/BF01061864
4. Ahmad, A., & Ghaffari, S. (2021). Pharmacokinetics. In StatPearls. StatPearls Publishing. Available from: NCBI StatPearls

Disclaimer